In addition to Treg cells, previous studies revealed that Foxp3 is also expressed in various cancers and promotes tumor progression by activating cancer-specific cellular pathways, such as the Wnt/β-catenin signaling pathway and EMT [28, 29]. The gene discussed is FOXP3; the disease is neoplasm.